Table 3 Comparison of clinical factors between LAT1 Low and LAT1 High groups.

From: Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma

 

LAT1 Low

LAT1 High

 

Age (years)

67.11 ± 8.31

69.70 ± 7.56

0.1850

Grade 3 or greater (%)

57.14

96.67

 < 0.0001*

pT stage 3 or greater (%)

47.06

96.97

 < 0.0001*

CRP (mg/dL)

1.39 ± 2.55

1.72 ± 2.95

0.6328

LDH (U/L)

177.71 ± 51.99

218.58 ± 36.89

0.0017*

ALT (IU/L)

12.47 ± 7.45

15.03 ± 32.14

0.6529

AST (IU/L)

17.76 ± 8.66

19.23 ± 15.24

0.6325

ALP (IU/L)

137.44 ± 113.93

133.48 ± 53.57

0.8606

Hb (g/dL)

9.74 ± 1.71

10.04 ± 1.70

0.4939

Alb (U/L)

3.65 ± 1.30

3.27 ± 1.29

0.3102

NLR (ng/mL)

2.81 ± 1.46

4.44 ± 1.85

0.0007*

IGFBP-5 staining score

1.02 ± 0.86

2.04 ± 0.85

 < 0.0001*

  1. Data are expressed as mean ± standard deviation unless otherwise indicated. LAT1 Low = low intensity of the LAT1 immunoreaction, LAT1 high = high intensity of the LAT1 immunoreaction, pT stage = pathological tumour stage, CRP = C-reactive protein, LDH = lactate dehydrogenase, ALT = alanine transaminase, AST = aminotransferase, ALP = alkaline phosphatase, Hb = haemoglobin, Alb = albumin, NLR = neutrophil-to-lymphocyte ratio. *means significant difference.
Back to article page